子宫内膜异位症行体外受精-胚胎移植助孕结局分析

目的：探讨子宫内膜异位症（EMs）伴不孕患者采用体外受精-胚胎移植（IVF-ET）助孕治疗的疗效。方法：回顾分析2013年44周期EMs不孕因素IVF-ET病历资料，同期102周期输卵管因素IVF-ET病例作对照。结果：两组年龄、不孕年限、BMI、Gn天数、Gn总量、内膜厚度、获卵数、2PN受精率、卵裂率、可移植胚胎数、平均移植胚胎数、优胚率、临床妊娠率、卵巢功能低下占比等数据比较，差异均无统计学意义。EMs组平均获卵数（9.77±6.20）个，可移植胚胎数（4.65±2.89）个，临床妊娠率50%（10/20），卵巢功能低下占比22.73%（10/44）。结论：EMs伴不孕患者采用IVF-ET助孕可获得与输卵管因素IVF-ET助孕相似的疗效。

The Analysis on IVF-ET for Endometriosis

Objective：To investigate the clinical effect of IVF-ET for endometriosis（EMs）. Method：44 cases of IVF-ET for EMs infertility in 2013 were retrospective analyzed,and 102 cases of IVF-ET for tubal infertility were selected as control. Result：For the factors like age,infertility time,BMI,the Gn days,total dose of the Gn,endometrium thickness,the number of eggs,2 PN fertilization rate,cleavage rate,valuable embryo numbers,the average number of embryo transfer,the ratio of good quality embryos,clinical pregnancy rate and the ratio of lower ovarian function,no significant differences were observed between the EMs group and the tubal infertility group. The EMs group average egg number was（9.77±6.20）,valuable embryo number was（4.65±2.89）,clinical pregnancy rate was 50%（10/20）,lower ovarian function accounted for 22.73%（10/44）. Conclusion：Patients who take IVF-ET with EMs or tubal infertility can obtain similar clinical effect.